INTERNATIONAL PATENT: DENALI THERAPEUTICS INC. FILES APPLICATION FOR "MODIFIED GLUCOCEREBROSIDASE POLYPEPTIDES AND METHODS OF USE THEREOF"

GENEVA, June 19 -- DENALI THERAPEUTICS INC. (161 Oyster Point Blvd.South San Francisco, California 94080) filed a patent application (PCT/US2024/058941) for "MODIFIED GLUCOCEREBROSIDASE POLYPEPTIDES AND METHODS OF USE THEREOF" on Dec 06, 2024. With publication no. WO/2025/122912, the details related to the patent application was published on Jun 12, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KARIOLIS, Mihalis S. (161 Oyster Point Blvd.South San Francisco, California 94080), QERQEZ, Ahlam Nabil (161 Oyster Point Blvd.South San Francisco, California 94080)

Abstract: Certain embodiments...